anonymous
Guest
anonymous
Guest
So upper management morons laid off about 15% of the cv team. Yet they haven’t changed the acquisition aspect for Leqvio and they haven’t made it easier for insurance companies to approve this damn drug. Also, doctor hate how the patients can’t administer it themselves. So when our drinking the kool aid managers give us the bullshit to tell the doctor that it helps their patient be compliant, they actually chuckled. Vas spent $9.5 billion to purchase Leqvio. There WILL be another lay off before the year ends